Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

被引:82
作者
Halberstadt, Adam L. [1 ]
Geyer, Mark A. [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA
关键词
Psychedelic; 5-HT2A; Head twitch; LSD; SEROTONIN 2A RECEPTOR; 5-HYDROXYTRYPTAMINE (5-HT)(2A); HIGH-AFFINITY; 5-HT2A; AGONIST; PHENETHYLAMINE; ANTAGONIST; MODULATION; ACTIVATION; BEHAVIOR;
D O I
10.1016/j.neuropharm.2013.08.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
N-benzyl substitution markedly enhances the affinity of phenethylamine hallucinogens at the 5-HT2A receptor. N-benzyl substituted derivatives of 2,5-dimethoxy-4-iodophenethylamine (2C-I), such as N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) and N-(2,3-methylenedioxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBMD), have appeared recently as designer drugs, but have not been characterized behaviorally. The head twitch response (HTR) is induced by 5-HT2A receptor activation in rats and mice, and is widely used as a behavioral proxy for hallucinogen effects in humans. Nevertheless, it is not clear whether phenethylamine hallucinogens reliably provoke this behavior. Hence, we investigated whether 2C-I, 25I-NBOMe and 25I-NBMD induce head twitches in C57BL/6J mice. The HTR was assessed using a head-mounted magnet and a magnetometer coil. 2C-I (1-10 mg/kg SC), 25I-NBOMe (0.1-1 mg/kg SC), and 25I-NBMD (1-10 mg/kg SC) induced the HTR. 25I-NBOMe displayed 14-fold higher potency than 2C-I, and the selective 5-HT2A antagonist M100,907 completely blocked the HTR induced by all three compounds. These findings show that phenethylamine hallucinogens induce the HTR by activating 5-HT2A receptors. Our results demonstrate that 25I-NBOMe is a highly potent derivative of 2C-I, confirming previous in vitro findings that N-benzyl substitution increases 5-HT2A affinity. Given the high potency and ease of synthesis of N-benzylphenethylamines, it is likely that the recreational use of these hallucinogens will become more widespread in the future. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 45 条
[21]  
Kehne JH, 1996, J PHARMACOL EXP THER, V277, P968
[22]  
Kelly A, 2012, CLIN TOXICOL, V50, P702
[23]   Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats [J].
Marek, Gerard J. .
NEUROPHARMACOLOGY, 2009, 56 (08) :1082-1087
[24]   Behavioral evidence for μ-opioid and 5-HT2A receptor interactions [J].
Marek, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 474 (01) :77-83
[25]   Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A.mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function [J].
Moreno, Jose L. ;
Muguruza, Carolina ;
Umali, Adrienne ;
Mortillo, Steven ;
Holloway, Terrell ;
Pilar-Cuellar, Fuencisla ;
Mocci, Giuseppe ;
Seto, Jeremy ;
Callado, Luis F. ;
Neve, Rachael L. ;
Milligan, Graeme ;
Sealfon, Stuart C. ;
Lopez-Gimenez, Juan F. ;
Javier Meana, J. ;
Benson, Deanna L. ;
Gonzalez-Maeso, Javier .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (53) :44301-44319
[26]   Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors [J].
Moya, Pablo R. ;
Berg, Kelly A. ;
Gutierrez-Hernandez, Manuel A. ;
Saez-Briones, Patricio ;
Reyes-Parada, Miguel ;
Cassels, Bruce K. ;
Clarke, William P. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (03) :1054-1061
[27]   High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):: A high-affinity 5-HT2A receptor-selective agonist radioligand [J].
Nichols, David E. ;
Frescas, Stewart P. ;
Chemel, Benjamin R. ;
Rehder, Kenneth S. ;
Zhong, Desong ;
Lewin, Anita H. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (11) :6116-6123
[28]   Hallucinogens [J].
Nichols, DE .
PHARMACOLOGY & THERAPEUTICS, 2004, 101 (02) :131-181
[29]   Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists [J].
Parrish, JC ;
Braden, MR ;
Gundy, E ;
Nichols, DE .
JOURNAL OF NEUROCHEMISTRY, 2005, 95 (06) :1575-1584
[30]   An in vivo binding assay to determine central α1-adrenoceptor occupancy using [3H]prazosin [J].
Patel, S ;
Fernandez-Garcia, E ;
Hutson, PH ;
Patel, S .
BRAIN RESEARCH PROTOCOLS, 2001, 8 (03) :191-198